Wagner Wealth Management (South Carolina)’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,100
Closed -$10K 725
2022
Q3
$10K Hold
2,100
0.01% 429
2022
Q2
$9K Buy
+2,100
New +$9.12K 0.01% 467
2022
Q1
Sell
-2,100
Closed -$16K 687
2021
Q4
$16K Hold
2,100
0.01% 433
2021
Q3
$13K Hold
2,100
0.01% 441
2021
Q2
$14K Hold
2,100
0.01% 447
2021
Q1
$17K Buy
+2,100
New +$17.1K 0.01% 390
2018
Q3
$20K Hold
2,100
0.01% 349
2018
Q2
$20K Hold
2,100
0.01% 319
2018
Q1
$22K Hold
2,100
0.02% 279
2017
Q4
$16K Buy
+2,100
New +$13K 0.01% 338

Other funds holding IMGN

Wagner Wealth Management (South Carolina)'s IMGN Position: Q4 2022 in Review

Wagner Wealth Management (South Carolina) sold out of Immunogen Inc (IMGN) in Q4 2022, closing a stake of 2,100 shares — an estimated $10K sold.

Wagner Wealth Management (South Carolina) first reported a position in IMGN in Q4 2017 and held it in 10 quarters. The position peaked at $22K in Q1 2018. 204 funds tracked by Wall St. Rank hold IMGN as of Q4 2022.

  • Wagner Wealth Management (South Carolina) reported no remaining Immunogen Inc position as of Q4 2022 after selling out during the quarter.
  • Wagner Wealth Management (South Carolina) sold 2,100 Immunogen Inc shares in Q4 2022, an estimated $10K.
  • Wagner Wealth Management (South Carolina) first reported a position in Immunogen Inc in Q4 2017 and held it in 10 quarters.
  • Wagner Wealth Management (South Carolina)'s Immunogen Inc position peaked at $22K in Q1 2018.
  • 204 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2022.

Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q4 2022, filed 14 Feb 2023.